Ignite Creation Date:
2024-05-06 @ 9:55 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03113760
Status:
COMPLETED
Last Update Posted:
2024-02-02
First Post:
2017-02-28
Brief Title:
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
Sponsor:
AB2 Bio Ltd
Organization:
AB2 Bio Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-02
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-28
First Submit QC Date:
April 10 2017
Study First Post Date:
2017-04-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-01
Last Update Post Date:
2024-02-02
Last Update Post Date Type:
ACTUAL